Diminished anti-retroviral therapy (ART) exposure and improved virological and immune outcomes with therapeutic vaccination after ART intensification, GM-CSF, and hydroxyurea in chronic HIV disease: a 5½-year pilot trial (CTN 140 study)
- E Toma (Speaker)
- M Loignon (Speaker)
- Sindhu, S. (Speaker)
- A Thorne (Speaker)
- D Zarowny (Speaker)
- NF Bernard (Speaker)
- L-G Labrecque (Speaker)
- C Tremblay (Speaker)
- L Cyr (Speaker)
- M-P Cordeau (Speaker)
- K Huang (Speaker)
- R Beaulieu (Speaker)
- José Menezes (Invited speaker)
Activity: Talk or presentation types › Oral presentation